医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
13期
50-50
,共1页
上消化道出血%内镜%生长抑素
上消化道齣血%內鏡%生長抑素
상소화도출혈%내경%생장억소
Upper gastrointestinal bleeding%Endoscopy%Somatostatin
目的分析急诊内镜下止血联合生长抑素治疗上消化道出血的临床价值。方法将本院2011年1月~2013年6月收治的86例上消化道出血患者随机均分为对照组与观察组，对照组采取常规治疗，观察组在对照组的基础上给予内镜下止血治疗，止血后联合应用生长抑素进行治疗。治疗结束后评估两组临床疗效，统计住院时间及再出血率，并进行对比分析。结果观察组治疗总有效率为97.67%，对照组为74.42%，观察组总有效率显著高于对照组，（P<0.01），显效率明显高于对照组，（P<0.05）；观察组住院时间显著少于对照组，（P<0.01），再出血率明显低于对照组，（P<0.05）。结论内镜下止血联合生长抑素治疗上消化道出血疗效可靠理想，再出血率低，可于临床治疗中推广应用。
目的分析急診內鏡下止血聯閤生長抑素治療上消化道齣血的臨床價值。方法將本院2011年1月~2013年6月收治的86例上消化道齣血患者隨機均分為對照組與觀察組，對照組採取常規治療，觀察組在對照組的基礎上給予內鏡下止血治療，止血後聯閤應用生長抑素進行治療。治療結束後評估兩組臨床療效，統計住院時間及再齣血率，併進行對比分析。結果觀察組治療總有效率為97.67%，對照組為74.42%，觀察組總有效率顯著高于對照組，（P<0.01），顯效率明顯高于對照組，（P<0.05）；觀察組住院時間顯著少于對照組，（P<0.01），再齣血率明顯低于對照組，（P<0.05）。結論內鏡下止血聯閤生長抑素治療上消化道齣血療效可靠理想，再齣血率低，可于臨床治療中推廣應用。
목적분석급진내경하지혈연합생장억소치료상소화도출혈적림상개치。방법장본원2011년1월~2013년6월수치적86례상소화도출혈환자수궤균분위대조조여관찰조，대조조채취상규치료，관찰조재대조조적기출상급여내경하지혈치료，지혈후연합응용생장억소진행치료。치료결속후평고량조림상료효，통계주원시간급재출혈솔，병진행대비분석。결과관찰조치료총유효솔위97.67%，대조조위74.42%，관찰조총유효솔현저고우대조조，（P<0.01），현효솔명현고우대조조，（P<0.05）；관찰조주원시간현저소우대조조，（P<0.01），재출혈솔명현저우대조조，（P<0.05）。결론내경하지혈연합생장억소치료상소화도출혈료효가고이상，재출혈솔저，가우림상치료중추엄응용。
Objective To analysis the emergency endoscopic hemostasis combined somatostatin clinical value for the treatment of upper gastrointestinal bleeding. Methods Our hospital between January 2011 and June 2013 were 86 cases of upper gastrointestinal hemorrhage patients were randomly divided into control group and observation group, control group treated with conventional, on the basis of the observation group in the control group given endoscopic hemostatic treatment, bleeding after the combined use of somatostatin for treatment. Evaluation of two groups after treatment of clinical curative effect, statistics in hospital time and bleeding rate, and comparison analysis. Results The observation group treatment the total ef ective rate was 97.67%, control group was 74.42%, the observation group total ef ective rate was significantly higher than that of control group( <0.01), the ef iciency is significantly higher than the control group( <0.05); The observation group had a significantly less than the control group, length of hospital stay ( <0.01), and bleeding rate is significantly lower than the control group ( < 0.05). Conclusion Endoscopic hemostasis combined somatostatin treatment of upper gastrointestinal hemorrhage curative ef ect is reliable, ideal and bleeding rate is low, can be applied in clinical treatment.
